NLM Digital Collections

Search

Search Constraints

Start Over You searched for: Subjects United States Remove constraint Subjects: United States

Search Results

6302. Cytomegalovirus in transplantation: developing drugs to treat or prevent disease

6304. COVID-19 public health emergency: general considerations for pre-IND meeting requests for COVID-19 related drugs and biological products : guidance for industry and investigators

6305. Supplements for Approved Premarket Approval (PMA) or Humanitarian Device Exemption (HDE) Submissions During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency: guidance for industry and Food and Drug Administration staff

6306. Postmarketing adverse event reporting for medical products and dietary supplements during a pandemic

6307. Policy for coronavirus disease-2019 tests during the public health emergency (revised): immediately in effect guidance for clinical laboratories, commercial manufacturers, and Food and Drug Administration staff

6309. Submission of plans for cigarette packages and cigarette advertisements (revised)

6310. Required warnings for cigarette packages and advertisements: small entity compliance guide (revised)